J. Van Gelder

648 total citations
15 papers, 444 citations indexed

About

J. Van Gelder is a scholar working on Infectious Diseases, Molecular Biology and Oncology. According to data from OpenAlex, J. Van Gelder has authored 15 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 9 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in J. Van Gelder's work include HIV/AIDS drug development and treatment (9 papers), Biochemical and Molecular Research (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). J. Van Gelder is often cited by papers focused on HIV/AIDS drug development and treatment (9 papers), Biochemical and Molecular Research (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). J. Van Gelder collaborates with scholars based in Belgium, Australia and Netherlands. J. Van Gelder's co-authors include Patrick Augustijns, Erik De Clercq, Renaat Kinget, Lieve Naesens, S. Deferme, Guy Van den Mooter, Guy Van den Mooter, Pieter Annaert, Xuan Ding and John P. Rose and has published in prestigious journals such as Journal of Controlled Release, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

J. Van Gelder

15 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Van Gelder Belgium	13	144	133	115	99	73	15	444
S. Deferme Belgium	13	297 2.1×	298 2.2×	117 1.0×	119 1.2×	118 1.6×	16	703
Doo‐Man Oh United States	10	188 1.3×	301 2.3×	76 0.7×	144 1.5×	68 0.9×	13	645
Chantal Masungi Belgium	8	160 1.1×	56 0.4×	169 1.5×	128 1.3×	56 0.8×	8	503
Jignesh Patel United States	10	187 1.3×	88 0.7×	46 0.4×	110 1.1×	89 1.2×	12	462
Scott D. Studenberg United States	12	186 1.3×	32 0.2×	241 2.1×	95 1.0×	153 2.1×	14	530
Gary D. Bowers United States	15	174 1.2×	31 0.2×	170 1.5×	188 1.9×	93 1.3×	24	620
Suresh Katragadda United States	10	108 0.8×	94 0.7×	63 0.5×	125 1.3×	38 0.5×	12	341
Isam I. Salem Jordan	15	37 0.3×	125 0.9×	33 0.3×	105 1.1×	47 0.6×	30	540
Constantin Efthymiopoulos United Kingdom	12	88 0.6×	138 1.0×	59 0.5×	96 1.0×	55 0.8×	16	636

Countries citing papers authored by J. Van Gelder

Since Specialization

Citations

This map shows the geographic impact of J. Van Gelder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Van Gelder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Van Gelder more than expected).

Fields of papers citing papers by J. Van Gelder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Van Gelder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Van Gelder. The network helps show where J. Van Gelder may publish in the future.

Co-authorship network of co-authors of J. Van Gelder

This figure shows the co-authorship network connecting the top 25 collaborators of J. Van Gelder. A scholar is included among the top collaborators of J. Van Gelder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Van Gelder. J. Van Gelder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Ding, Xuan, John P. Rose, & J. Van Gelder. (2012). Developability assessment of clinical drug products with maximum absorbable doses. International Journal of Pharmaceutics. 427(2). 260–269. 23 indexed citations

Palumbo, Pasquale, et al.. (2008). A general approach to the apparent permeability index. Journal of Pharmacokinetics and Pharmacodynamics. 35(2). 235–248. 38 indexed citations

Rieux, Anne des, Virginie Fiévez, Christophe Detrembleur, et al.. (2006). Helodermin-loaded nanoparticles: Characterization and transport across an in vitro model of the follicle-associated epithelium. Journal of Controlled Release. 118(3). 294–302. 47 indexed citations

Gelder, J. Van, S. Deferme, Lieve Naesens, et al.. (2002). Intestinal Absorption Enhancement of the Ester Prodrug Tenofovir Disoproxil Fumarate through Modulation of the Biochemical Barrier by Defined Ester Mixtures. Drug Metabolism and Disposition. 30(8). 924–930. 81 indexed citations

Deferme, S., J. Van Gelder, F. Ingels, et al.. (2002). Intestinal absorption characteristics of the low solubility thiocarboxanilide UC-781. International Journal of Pharmaceutics. 234(1-2). 113–119. 21 indexed citations

Deferme, S., J. Van Gelder, & Patrick Augustijns. (2002). Inhibitory effect of fruit extracts on P-glycoproteinrelated efflux carriers: an in-vitro screening. Journal of Pharmacy and Pharmacology. 54(9). 1213–1219. 35 indexed citations

Gelder, J. Van, Erik De Clercq, Freddy Penninckx, et al.. (2000). Species-dependent and site-specific intestinal metabolism of ester prodrugs. International Journal of Pharmaceutics. 205(1-2). 93–100. 52 indexed citations

Annaert, Pieter, Josef J. Tukker, J. Van Gelder, et al.. (2000). In Vitro, Ex Vivo, and In Situ Intestinal Absorption Characteristics of the Antiviral Ester Prodrug Adefovir Dipivoxil. Journal of Pharmaceutical Sciences. 89(8). 1054–1062. 30 indexed citations

Augustijns, Patrick, J. Van Gelder, Guy Van den Mooter, et al.. (2000). Oral absorption characteristics of the antiviral agent UC-781. 1 indexed citations

10.

Gelder, J. Van, S. Deferme, Pieter Annaert, et al.. (2000). Increased Absorption of the Antiviral Ester Prodrug Tenofovir Disoproxil in Rat Ileum by Inhibiting Its Intestinal Metabolism. Drug Metabolism and Disposition. 28(12). 1394–1396. 36 indexed citations

11.

Gelder, J. Van, S. Deferme, Guy Van den Mooter, et al.. (2000). Increased oral absorption of the antiviral ester prodrug Tenofovir disoproxil in rat ileum. 3 indexed citations

12.

Gelder, J. Van, Myriam Witvrouw, Christophe Pannecouque, et al.. (1999). Evaluation of the potential of ion pair formation to improve the oral absorption of two potent antiviral compounds, AMD3100 and PMPA. International Journal of Pharmaceutics. 186(2). 127–136. 25 indexed citations

13.

Gelder, J. Van, Pieter Annaert, Lieve Naesens, et al.. (1999). Inhibition of Intestinal Metabolism of the Antiviral Ester Prodrug bis(POC)-PMPA by Nature-Identical Fruit Extracts as a Strategy to Enhance Its Oral Absorption: An In Vitro Study. Pharmaceutical Research. 16(7). 1035–1040. 18 indexed citations

14.

Annaert, Pieter, J. Van Gelder, Lieve Naesens, et al.. (1998). Carrier Mechanisms Involved in the Transepithelial Transport of bis(POM)-PMEA and Its Metabolites Across Caco-2 Monolayers. Pharmaceutical Research. 15(8). 1168–1173. 17 indexed citations

15.

Lepore, Diana A., K.R. Knight, J. Van Gelder, et al.. (1995). Cool perfusion solutions for skin flaps: a new mixture of pharmacological agents which improves skin flap viability. British Journal of Plastic Surgery. 48(3). 132–144. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact